(Q38118503)

English

LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both

scientific article published on July 2013

In more languages
default for all languages
No label defined

No description defined

Statements

LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both (English)
Kunihiko Koboyashi
Nobuyuki Yamamoto

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit